30Ventures

AIQ Solutions, Inc. specializes in the development of medical devices and software solutions aimed at the quantitative assessment of lesions related to complex diseases, primarily cancer. The company's clinical decision support platform analyzes medical imaging data to identify and quantify all lesions in cancer patients, tracking changes post-treatment. AIQ Solutions offers innovative products such as quantitative total bone imaging (QTBI), which provides insights into metastatic bone disease, and quantitative total marrow imaging (QTMI), which assesses disease heterogeneity and treatment response in bone marrow. Founded in 2015 and based in Madison, Wisconsin, the company emerged from the University of Wisconsin Translational Imaging Research Program, with its founders possessing extensive experience in drug development and clinical trials. AIQ Solutions has received FDA 510(k) clearance for its QTxI platform, reinforcing its commitment to enhancing patient management and outcomes in oncology. Its products serve oncologists, radiologists, nuclear medicine physicians, and pharmaceutical companies.

Pops Diabetes Care is a digital health company that provides a virtual healthcare platform designed to help individuals manage diabetes effectively. The platform combines consumer-centric sensors with artificial intelligence-driven virtual coaches, allowing users to monitor their glucose levels and receive personalized feedback through their smartphones. This approach aims to simplify diabetes management, making it less intrusive and more accessible. The company's patented, FDA-cleared Rebel virtual care system enhances user experience by ensuring that diabetes management is discreet and easy to use. Through this innovative platform, Pops Diabetes Care has demonstrated the potential to significantly reduce glucose levels, resulting in substantial annual savings for users.

Made In is a direct-to-consumer premium, American, cookware brand that creates better tools for modern cooks at an affordable price. they aim to become the go-to kitchen brand for Millenials across all kitchen categories.

TAI Diagnostics, Inc. is a biotechnology company based in Wauwatosa, Wisconsin, established in 2013. The company specializes in developing non-invasive diagnostic tests aimed at monitoring the health of transplanted organs in patients who have undergone solid organ transplants. Utilizing advanced cell-free DNA (cf-DNA) technology, TAI Diagnostics' test quantifies donor-specific cf-DNA released into the bloodstream from injured cells of a transplanted organ, allowing for early detection of organ rejection. This innovative approach enables physicians to perform regular surveillance biopsies, ultimately enhancing patient care and outcomes in the transplant community. The company is situated in the Milwaukee County Research Park, adjacent to significant medical institutions, positioning it within a vibrant healthcare ecosystem.